BIOG vs. IEM, BGSC, ICGT, SLS, ESCT, VOF, TRG, GSCT, SDP, and APAX
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Impax Environmental Markets (IEM), BMO Global Smaller Companies (BGSC), ICG Enterprise Trust (ICGT), Standard Life UK Smaller Companies Trust (SLS), The European Smaller Companies Trust (ESCT), VinaCapital Vietnam Opp Fund (VOF), The European Smaller Companies Trust (TRG), The Global Smaller Companies Trust (GSCT), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), and Apax Global Alpha (APAX). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs.
The Biotech Growth Trust (LON:BIOG) and Impax Environmental Markets (LON:IEM) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.
The Biotech Growth Trust has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Impax Environmental Markets has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500.
The Biotech Growth Trust has a net margin of 95.33% compared to Impax Environmental Markets' net margin of -691.26%. The Biotech Growth Trust's return on equity of 26.96% beat Impax Environmental Markets' return on equity.
The Biotech Growth Trust has higher revenue and earnings than Impax Environmental Markets. Impax Environmental Markets is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks.
28.6% of The Biotech Growth Trust shares are held by institutional investors. Comparatively, 41.2% of Impax Environmental Markets shares are held by institutional investors. 0.7% of The Biotech Growth Trust shares are held by company insiders. Comparatively, 2.8% of Impax Environmental Markets shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, The Biotech Growth Trust had 1 more articles in the media than Impax Environmental Markets. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for Impax Environmental Markets. The Biotech Growth Trust's average media sentiment score of 1.86 beat Impax Environmental Markets' score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.
The Biotech Growth Trust received 13 more outperform votes than Impax Environmental Markets when rated by MarketBeat users. However, 66.99% of users gave Impax Environmental Markets an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.
Summary
The Biotech Growth Trust beats Impax Environmental Markets on 10 of the 15 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 4/18/2025 by MarketBeat.com Staff